ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,474,606 | +3.8% | 118,743 | -6.2% | 0.00% | 0.0% |
| Q2 2023 | $2,382,894 | 0.0% | 126,615 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,382,894 | -99.9% | 126,615 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $2,015,570,000 | -76.7% | 123,201 | -80.0% | 0.00% | -80.0% |
| Q2 2022 | $8,658,826,000 | -37.5% | 614,537 | +7.4% | 0.01% | -16.7% |
| Q1 2022 | $13,862,196,000 | +9.6% | 572,345 | +5.6% | 0.01% | +20.0% |
| Q4 2021 | $12,650,117,000 | +64.2% | 541,993 | +16.9% | 0.01% | +66.7% |
| Q3 2021 | $7,703,851,000 | -34.9% | 463,808 | -4.4% | 0.00% | -40.0% |
| Q2 2021 | $11,827,614,000 | +13.6% | 484,937 | +20.1% | 0.01% | 0.0% |
| Q1 2021 | $10,413,525,000 | -66.1% | 403,625 | -29.8% | 0.01% | -64.3% |
| Q4 2020 | $30,731,213,000 | +26.3% | 574,845 | -2.5% | 0.01% | +7.7% |
| Q3 2020 | $24,326,198,000 | -45.4% | 589,726 | -35.9% | 0.01% | -51.9% |
| Q2 2020 | $44,575,630,000 | +36.0% | 919,654 | +18.6% | 0.03% | +12.5% |
| Q1 2020 | $32,769,186,000 | -11.0% | 775,602 | -9.9% | 0.02% | +4.3% |
| Q4 2019 | $36,824,896,000 | +817.6% | 860,797 | +672.0% | 0.02% | +666.7% |
| Q3 2019 | $4,013,208,000 | +43.6% | 111,509 | +6.6% | 0.00% | +50.0% |
| Q2 2019 | $2,795,076,000 | +10.4% | 104,567 | +10.9% | 0.00% | 0.0% |
| Q1 2019 | $2,531,794,000 | +92.8% | 94,294 | +16.1% | 0.00% | +100.0% |
| Q4 2018 | $1,312,923,000 | -7.7% | 81,195 | +18.4% | 0.00% | 0.0% |
| Q3 2018 | $1,423,057,000 | +36.0% | 68,548 | +0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,046,439,000 | -92.4% | 68,529 | -88.8% | 0.00% | -90.9% |
| Q1 2018 | $13,743,686,000 | -48.7% | 611,646 | -31.2% | 0.01% | -52.2% |
| Q4 2017 | $26,779,111,000 | -9.5% | 889,376 | +13.2% | 0.02% | -14.8% |
| Q3 2017 | $29,600,821,000 | +37.6% | 785,793 | +1.8% | 0.03% | +28.6% |
| Q2 2017 | $21,519,003,000 | -11.9% | 771,567 | +8.6% | 0.02% | -16.0% |
| Q1 2017 | $24,422,417,000 | +122398.0% | 710,367 | +2.8% | 0.02% | +13.6% |
| Q4 2016 | $19,937,000 | -12.6% | 691,343 | -3.6% | 0.02% | -12.0% |
| Q3 2016 | $22,805,000 | +6.9% | 716,936 | +9.1% | 0.02% | +4.2% |
| Q2 2016 | $21,331,000 | -5.3% | 657,156 | -18.4% | 0.02% | -7.7% |
| Q1 2016 | $22,522,000 | -17.6% | 805,484 | +5.1% | 0.03% | -16.1% |
| Q4 2015 | $27,317,000 | +8.2% | 766,260 | +0.4% | 0.03% | +10.7% |
| Q3 2015 | $25,244,000 | -28.7% | 763,375 | -9.7% | 0.03% | -17.6% |
| Q2 2015 | $35,396,000 | +59.5% | 845,177 | +24.1% | 0.03% | +61.9% |
| Q1 2015 | $22,198,000 | +2.9% | 681,131 | +0.2% | 0.02% | 0.0% |
| Q4 2014 | $21,578,000 | +2580.5% | 679,631 | +1989.2% | 0.02% | +2000.0% |
| Q3 2014 | $805,000 | +9.8% | 32,531 | +0.3% | 0.00% | 0.0% |
| Q2 2014 | $733,000 | -7.1% | 32,431 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $789,000 | +56.2% | 32,431 | +60.5% | 0.00% | 0.0% |
| Q4 2013 | $505,000 | -38.7% | 20,200 | -32.7% | 0.00% | 0.0% |
| Q3 2013 | $824,000 | +150.5% | 30,000 | +65.7% | 0.00% | – |
| Q2 2013 | $329,000 | – | 18,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |